Security key
137404109
Candel Therapeutics, Inc. - Common Stock (CADL)
CUSIP: 137404109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,961,761
- Total 13F value
- $36,964,279
- Share change
- +2,170,843
- Put/Call ratio
- 68%
- SEC-reported price per share
- $6.20
- Number of holders
- 45
- Value change
- +$13,959,987
- Number of buys
- 39
- Number of sells
- 10
- Shares outstanding
- 73,256,045
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
45
Top holders
10
CADL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Candel Therapeutics, Inc. SEC filings
Candel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 137404109
Recent filing periods:
Ownership snapshot
Top reported holders of CADL - Candel Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Northpond Ventures, LLC
Disclosed value leader
Northpond Ventures, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 2.6%
Showing 1-6 of 15 holder rows.
Quick read
Northpond Ventures, LLC leads the comparable SEC ownership view at 2.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Northpond Ventures, LLC's linked filing trail.
Comparable ownership
Top 5
Northpond Ventures, LLC
2.6%
Sands Capital Alternatives, LLC
1.1%
VANGUARD GROUP INC
0.74%
GEODE CAPITAL MANAGEMENT, LLC
0.2%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Northpond Ventures, LLC |
13F
Company
|
2.6%
|
$3,057,640
1,935,215 shares
|
— | 31 Mar 2024 |
| Sands Capital Alternatives, LLC |
13F
Company
|
1.1%
|
$1,282,544
811,737 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.74%
|
$855,246
541,295 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.2%
|
$230,256
145,706 shares
|
— | 31 Mar 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.11%
|
$130,500
82,595 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.08%
|
$90,000
56,905 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
5,961,761
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
18
Q2 2024 holders
45
Holder diff
27
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend